Cryo-Cell Intl Inc (CCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 08-2019 | 05-2019 | 02-2019 | 11-2018 | 08-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,339 | 6,469 | 7,076 | 6,040 | 7,040 |
| Marketable Securities | 875 | 840 | 809 | 876 | 950 |
| Receivables | 5,888 | 5,759 | 5,694 | 5,867 | 5,513 |
| Inventories | 1,032 | 1,046 | 16,133 | 1,261 | 16,170 |
| Other current assets | 260 | 278 | 205 | 255 | 209 |
| TOTAL | $15,920 | $15,002 | $30,376 | $14,760 | $30,479 |
| Non-Current Assets | |||||
| PPE Net | 1,769 | 1,748 | 1,465 | 1,493 | 1,540 |
| Investments And Advances | 308 | 308 | 308 | 308 | 308 |
| Intangibles | 3,210 | 3,229 | 3,256 | 3,283 | 3,376 |
| Other Non-Current Assets | 20,621 | 20,603 | 7,938 | 22,546 | 6,947 |
| TOTAL | $25,908 | $25,887 | $12,966 | $27,630 | $12,172 |
| Total Assets | $41,828 | $40,889 | $43,342 | $42,390 | $42,650 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,013 | 1,029 | 1,010 | 1,262 | 1,120 |
| Accrued Expenses | 1,373 | 965 | 2,902 | 2,703 | 2,483 |
| TOTAL | $14,267 | $13,611 | $15,279 | $15,430 | $14,913 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,605 | 8,352 | 9,098 | 9,844 | 11,589 |
| Deferred Revenues | 8,781 | 8,517 | 8,267 | 8,365 | 8,210 |
| Other Non-Current Liabilities | 5,027 | 5,037 | 6,075 | 5,708 | 6,123 |
| TOTAL | $34,524 | $35,373 | $36,298 | $35,869 | $37,586 |
| Total Liabilities | $48,791 | $48,983 | $51,577 | $51,298 | $52,499 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,803 | 7,803 | 7,803 | 7,803 | 7,801 |
| Common Shares | 136 | 136 | 136 | 136 | 136 |
| Retained earnings | -23,289 | -24,406 | -24,459 | -25,330 | -26,220 |
| Other shareholders' equity | 429 | 429 | 429 | 770 | 875 |
| TOTAL | $-6,963 | $-8,094 | $-8,234 | $-8,908 | $-9,849 |
| Total Liabilities And Equity | $41,828 | $40,889 | $43,342 | $42,390 | $42,650 |